All News

Greater Sleep Disturbance Associated With External Factors in Patients With GI Cancers
May 10, 2021

In patients with gastrointestinal cancers, factors such as younger age and comorbidities, among others, were significantly associated with a greater likelihood of sleep disturbance.

Datopotamab Deruxtecan Shows Promise in Heavily Pretreated Triple-Negative Breast Cancer
May 10, 2021

The TROP2-directed antibody-drug conjugate datopotamab deruxtecan induced responses and an acceptable safety profile in a cohort of patients with triple-negative breast cancer treated on a phase 1 trial.

Kathryn Maples, PharmD, BCOP, on the REMS Program for Belantamab Mafodotin
May 10, 2021

A clinical pharmacy specialist details her experience with the REMS program for administration of belantamab mafodotin in patients with multiple myeloma.